Piper Sandler analyst Christopher Donat maintains Mastercard (NYSE:MA) with a Underweight and lowers the price target from $357 to $298.
Avalon GloboCare Announces Closing Of Strategic Investment In Laboratory Services MSO, A Leading Clinical Diagnostics And Reference Laboratory Company; Total Consideration For The Transaction Was $21M
Transaction Expected to Be Accretive to Earnings Through Profit Sharing Agreement
Adds Strong Clinical Synergies to Existing Avalon Portfolio
Marks Launch of New Roll-Up Strategy Targeting Toxicology and